U.S. flag

An official website of the United States government

NM_031443.4(CCM2):c.30+5_30+6delinsTT AND not provided

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Aug 2, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000339043.19

Allele description [Variation Report for NM_031443.4(CCM2):c.30+5_30+6delinsTT]

NM_031443.4(CCM2):c.30+5_30+6delinsTT

Genes:
LOC129998395:ATAC-STARR-seq lymphoblastoid silent region 18162 [Gene]
CCM2:CCM2 scaffold protein [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_031443.4(CCM2):c.30+5_30+6delinsTT
HGVS:
  • NC_000007.14:g.45000368_45000369delinsTT
  • NG_016295.1:g.5181_5182delinsTT
  • NM_001167934.2:c.30+5_30+6delinsTT
  • NM_001167935.2:c.30+5_30+6delinsTT
  • NM_001363458.2:c.30+5_30+6delinsTT
  • NM_001363459.2:c.30+5_30+6delinsTT
  • NM_031443.4:c.30+5_30+6delinsTTMANE SELECT
  • LRG_664t2:c.30+5_30+6delinsTT
  • LRG_664:g.5181_5182delinsTT
  • NC_000007.13:g.45039967_45039968delinsTT
  • NM_031443.3:c.30+5_30+6delGCinsTT
  • NM_031443.3:c.30+5_30+6delinsTT
Links:
OMIM: 607929.0010; dbSNP: rs797044623
NCBI 1000 Genomes Browser:
rs797044623
Molecular consequence:
  • NM_001167934.2:c.30+5_30+6delinsTT - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001167935.2:c.30+5_30+6delinsTT - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001363458.2:c.30+5_30+6delinsTT - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001363459.2:c.30+5_30+6delinsTT - intron variant - [Sequence Ontology: SO:0001627]
  • NM_031443.4:c.30+5_30+6delinsTT - intron variant - [Sequence Ontology: SO:0001627]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000224657Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(Mar 11, 2015)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV000329216GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Aug 2, 2024)
germlineclinical testing

Citation Link,

SCV000612714Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Likely pathogenic
(Jun 6, 2023)
unknownclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown1not providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Cerebral Cavernous Malformation 2 Syndrome Presenting With Retinal Cavernous Hemangioma and Sixth Cranial Nerve Palsy.

Khan MJ, Dinkin M, D'Amico DJ.

JAMA Ophthalmol. 2021 Mar 1;139(3):e204104. doi: 10.1001/jamaophthalmol.2020.4104. Epub 2021 Mar 17. No abstract available.

PubMed [citation]
PMID:
33729445

A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.

Gallione CJ, Solatycki A, Awad IA, Weber JL, Marchuk DA.

Genet Med. 2011 Jul;13(7):662-6. doi: 10.1097/GIM.0b013e318211ff8b.

PubMed [citation]
PMID:
21543988
PMCID:
PMC3132303
See all PubMed Citations (4)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000224657.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From GeneDx, SCV000329216.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Non-canonical splice site variant demonstrated to result in loss-of-function (PMID: 21543988, 23595507); This variant is associated with the following publications: (PMID: 23595507, 33729445, 21543988)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Athena Diagnostics, SCV000612714.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in multiple unrelated individuals with clinical features associated with this gene. Assessment of experimental evidence suggests this variant results in abnormal RNA splicing (PMID: 21543988, 23595507).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024